Want to see IRON full AI Analyst Report?
Disc Medicine (IRON) Ratios
Disc Medicine Ratios
IRON's free cash flow for Q2 2026 was $-44.20M. For the 2026 fiscal year, IRON's free cash flow was increased by $0.00 and operating cash flow was $-44.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 |
| Quick Ratio | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 |
| Cash Ratio | 2.49 | 8.25 | 16.81 | 8.62 | 6.56 |
| Solvency Ratio | -3.16 | -2.05 | -3.34 | -1.98 | -0.23 |
| Operating Cash Flow Ratio | -4.92 | -4.03 | -3.43 | -1.87 | -2.05 |
| Short-Term Operating Cash Flow Coverage | -295.24 | 0.00 | 0.00 | 0.00 | -5.51 |
| Net Current Asset Value | $ 736.85M | $ 440.43M | $ 342.79M | $ 174.89M | $ -66.13M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.06 | 0.01 | 0.01 | 0.08 |
| Debt-to-Equity Ratio | 0.00 | 0.07 | 0.01 | 0.01 | -0.11 |
| Debt-to-Capital Ratio | 0.00 | 0.06 | 0.01 | 0.01 | -0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.06 | 0.00 | 0.00 | -0.01 |
| Financial Leverage Ratio | 1.09 | 1.12 | 1.07 | 1.13 | -1.44 |
| Debt Service Coverage Ratio | -49.38 | -189.91 | 0.00 | 0.00 | -4.32 |
| Interest Coverage Ratio | -65.43 | -226.78 | 0.00 | 0.00 | -14.33 |
| Debt to Market Cap | 0.00 | 0.02 | 0.00 | 0.00 | 0.23 |
| Interest Debt Per Share | 0.16 | 1.11 | 0.09 | 1.28 | 11.50 |
| Net Debt to EBITDA | 0.43 | 1.50 | 4.70 | 4.08 | 2.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.17% | 100.33% | 100.13% | 100.00% | 100.00% |
| EBT Per EBIT | 89.75% | 84.03% | 83.76% | 98.64% | 116.28% |
| Return on Assets (ROA) | -26.30% | -22.01% | -20.77% | -23.39% | -38.92% |
| Return on Equity (ROE) | -28.68% | -24.65% | -22.15% | -26.52% | 56.02% |
| Return on Capital Employed (ROCE) | -30.64% | -27.40% | -26.29% | -26.73% | -39.16% |
| Return on Invested Capital (ROIC) | -30.62% | -27.39% | -26.24% | -26.68% | -36.69% |
| Return on Tangible Assets | -26.30% | -22.01% | -20.77% | -23.39% | -38.92% |
| Earnings Yield | -7.57% | -6.25% | -5.93% | -226.49% | -154.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.11 | -3.40 | -3.29 | -40.65 | -34.35 |
| Free Cash Flow Per Share | -5.14 | -3.42 | -3.30 | -40.79 | -34.44 |
| Dividend Paid and CapEx Coverage Ratio | -193.35 | -185.99 | -825.42 | -279.81 | -404.91 |
| Capital Expenditure Coverage Ratio | -193.35 | -185.99 | -825.42 | -279.81 | -404.91 |
| Operating Cash Flow Coverage Ratio | -96.78 | -3.13 | -34.97 | -31.67 | -3.90 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -6.47% | -5.40% | -5.71% | -205.09% | -118.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.21 | -16.01 | -16.86 | -0.44 | -0.65 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.79 | 3.95 | 3.73 | 0.12 | -0.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.46 | -18.53 | -17.52 | -0.49 | -0.84 |
| Price-to-Operating Cash Flow Ratio | -15.54 | -18.63 | -17.55 | -0.49 | -0.85 |
| Price-to-Earnings Growth (PEG) Ratio | -0.26 | -1.01 | 0.18 | -1.17 | -0.01 |
| Enterprise Value Multiple | -13.05 | -14.66 | -12.21 | 3.64 | 1.87 |
| Enterprise Value | 2.71B | 1.59B | 930.68M | -172.60M | -57.66M |
| EV to EBITDA | -13.05 | -14.66 | -12.21 | 3.64 | 1.87 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.97 | -16.81 | -12.65 | 4.07 | 2.09 |
| EV to Operating Cash Flow | -15.04 | -16.90 | -12.67 | 4.09 | 2.09 |
| Tangible Book Value Per Share | 20.96 | 16.07 | 15.47 | 169.89 | -80.11 |
| Shareholders’ Equity Per Share | 20.96 | 16.07 | 15.47 | 169.89 | -80.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.01 | 1.00 | 0.99 | 1.16 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.86 | 0.96 | 0.90 | 0.77 |
Currency in USD
